Palliative care providers face a host of legal and regulatory challenges when seeking to expand patients’ access to certain controlled substances. Providing therapeutic- and medically-guided patient experiences involves a deep understanding of compliance with evolving laws and safe utilization. Drugs that fall into the realm of federally controlled substances include cannabis, ketamine, MDMA and psychedelics […]